Powder Delivery TRIZ Cases

Cannabinoid-conjugated gold nanoparticles deliver high drug payloads via intravenous or localized routes.

Sugar-coated melanin nanoparticles absorb nonionizing radiation to induce localized hyperthermia in metastatic cancer cells.

A silica-coated polyplex nanoparticle protects polynucleotide payloads through electrostatic interactions and physical containment.

Functionalized nanoparticles bind tumor cells within a biodegradable polymer matrix to enable precise migration tracking.

A colloidal exosome suspension stabilized by carboxylated epsilon-poly-L-lysine cryoprotectant maintains biological integrity during ambient storage.

A capsule filled with radiopaque markers simulates chyme movement to track gastrointestinal motility via X-ray imaging.

Hollow silica nanospheres attach DNA to enhance uptake by dendritic cells, addressing low vaccine efficacy in non-proliferating cancer cells.

Artificial virus nanoparticles with defined ganglioside GM3 layers mimic viral surfaces to target CD169-expressing cells.

Spray freezing and atmospheric gas drying preserves biological activity while avoiding protein degradation from heat or slow vacuum processes.

Electrostatic bonding stabilizes chitosan-tannin composites, resolving mechanical weakness while maintaining biocompatibility.

A water-soluble realgar solid dispersion induces erythroid differentiation in bone marrow cells.

A self-gelling drug delivery system uses hydrophilic and hydrophobic matrices to control release rates.

Formula I compounds and sugars protect polypeptides during drying, eliminating cold storage needs.

Cellulose acetate base retains active peptides for enhanced nasal absorption while preventing mucosal irritation.

Sol-gel derived SiO2 prepared with controlled pH and molar ratios to achieve tailored bioresorption rates.

Nanoparticles combine checkpoint inhibition with co-stimulation to bypass tumor suppression.

Segmenting N-acetylcysteine into immediate and sustained release components reduces C-reactive protein levels while minimizing undesirable side effects.

Visible wavelength excitation extends observation time beyond sixty minutes while eliminating autofluorescence interference through persistent emission.

A methionine-containing pharmaceutical composition stabilizes bispecific antibody constructs during frozen storage.

ApoE receptor-binding domains mediate fusion protein transport across the blood-brain barrier, enabling metabolic correction in neurological disorders.

A defucosylated human monoclonal antibody binds tumor necrosis factor receptor 2 to promote antibody-dependent cell-mediated cytotoxicity.

A pre-lyophilization formulation containing buffering agents and stabilizing agents preserves Factor IX polypeptide integrity.

Christensenella sp. P152-H6d bacterial strain increases anti-inflammatory cytokine secretion levels in the human intestine.

Biodegradable microparticles encapsulate glatiramer acetate to enable prolonged release, reducing daily injection frequency and side effects.

Bioencapsulated ACE2 in plant cells enables oral delivery, solving protein stability and manufacturing cost challenges.

Hybrid multifunctional macromers self-assemble into nanoparticles that release morphogens via enzymatic cleavage.

A high penetration prodrug links a functional unit to a transportational unit via a cleavable linker.

Adding trehalose as a cryoprotectant maintains over 90% of Factor IX biological activity and prevents aggregation during storage at elevated temperatures.

Targeted particles react with reactive oxygen species to emit luminescence for direct in-vivo imaging.

Coating microneedles with submicron particles and binding agents reduces drug loading variation while maintaining sharp tips for reliable skin puncture.

Tissue regeneration particles use controlled secondary porosity to enhance interparticle spacing.

Liposomal apelin peptide formulations boost host cellular defenses and ACE2 activity to resist viral penetration without requiring continuous vaccine updates.

A lyophilized matrix reconstitutes into gas-filled microbubble suspensions for diagnostic imaging.

A nanomedicinal composition delivers platinum complexes to target cells while protecting healthy tissue.

A dental composite material incorporates microcapsules containing an oligomeric curing agent to repair fractures through polymerization.

Segmented ACE2 variants bypass large molecular size limits to enable glomerular filtration and deliver renoprotective effects.

Hybrid enzyme-silica nanoparticles shield biological catalysts within a protective nanoshell.

A polyorthoester delivery vehicle releases local anesthetics and NSAIDs through hydrolysis.

Protease-cleavable linkers trigger localized release of therapeutic polypeptides at disease sites, minimizing systemic toxicity.

A fluidized-bed device grows microgranules from extract powder using a binder solution to form high-concentration pills.

Volatile organic solvent coating on water-soluble substrates creates stable aqueous dispersions of heat-sensitive drugs without thermal degradation.

DNAJB1-PRKACA peptides bind MHC molecules to induce T cell responses, addressing the lack of specific epitopes in fibrolamellar hepatocellular carcinoma.

Homogenization achieves consistent particle size for penicillin G procaine, resolving batch quality variability from milling.

Composite particles generate free radicals via X-ray excitation.

Molecular sieves in the desiccant chamber absorb ambient humidity, ensuring pharmaceutical composition stability and flowability in high-humidity climates.